Royce & Associates LP Sells 79,223 Shares of Privia Health Group, Inc. $PRVA

Royce & Associates LP lowered its position in shares of Privia Health Group, Inc. (NASDAQ:PRVA – Free Report) by 9.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 745,948 shares of the company’s stock after selling 79,223 shares during the period. Royce & Associates LP owned 0.58% of Privia Health Group worth $14,688,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. purchased a new stake in Privia Health Group in the 2nd quarter worth approximately $550,684,000. Rubicon Founders LLC purchased a new position in shares of Privia Health Group during the 2nd quarter valued at $153,635,863. Van Berkom & Associates Inc. increased its holdings in shares of Privia Health Group by 5.4% in the first quarter. Van Berkom & Associates Inc. now owns 4,053,043 shares of the company’s stock worth $83,371,000 after purchasing an additional 208,787 shares during the period. Bank of New York Mellon Corp bought a new position in shares of Privia Health Group in the second quarter worth $74,425,000. Finally, Wellington Management Group LLP increased its holdings in shares of Privia Health Group by 850.6% in the second quarter. Wellington Management Group LLP now owns 2,130,289 shares of the company’s stock worth $54,812,000 after purchasing an additional 1,906,187 shares during the period. Institutional investors own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Zacks Research upgraded Privia Health Group from a “strong sell” rating to a “hold” rating in a research report on Wednesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Privia Health Group in a research report on Tuesday, September 29th. Citigroup restated a “buy” rating on shares of Privia Health Group in a research report on Thursday, July 23rd. Piper Sandler upped their target price on Privia Health Group from $36.00 to $38.00 and gave the stock an “overweight” rating in a research note on Friday, November 6th. Finally, Canaccord Genuity Group raised their price target on Privia Health Group from $32.00 to $33.00 and gave the company a “buy” rating in a report on Friday, November 6th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $31.20.

View Our Latest Stock Analysis on Privia Health Group

Privia Health Group Price Performance

Shares of Privia Health Group stock opened at $25.26 on Tuesday. Privia Health Group, Inc. has a 1 year low of $18.92 and a 1 year high of $28.82. The firm has a market cap of $3.23 billion, a PE ratio of 97.16 and a beta of 0.76. The company has a 50 day simple moving average of $21.49 and a two-hundred day simple moving average of $22.66.

Privia Health Group (NASDAQ:PRVA – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.12. The business had revenue of $656.96 million during the quarter, compared to analysts’ expectations of $610.72 million. Privia Health Group had a net margin of 1.43% and a return on equity of 4.20%. The business’s quarterly revenue was up 13.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.29 EPS. As a group, research analysts anticipate that Privia Health Group, Inc. will post 0.27 earnings per share for the current year.

Privia Health Group Profile

(Free Report)

Privia Health Group, Inc. is a physician enablement company that partners with independent medical groups, health systems and other providers. Its technology-enabled platform is designed to help physicians manage their practices and deliver coordinated care, while retaining their clinical independence. The company provides practice management, technology, care coordination and population health services. It also helps providers participate in value-based care arrangements, which tie payments more closely to the quality and efficiency of care.

Further Reading

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.